bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Crinetics Pharmaceuticals Inc. logo

    Crinetics Pharmaceuticals Inc.

    CRNX | NASDAQ
    Chart Builder DCF Calculator
    $84.95
    $0 (0.00%)
    Sep 1, 2026, 9:30 AM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $9B
    Enterprise Value
    $7.84B
    Beta
    0.13
    Average Volume
    3.69M
    Shares Outstanding (Diluted)
    105.56M
    Shares Change YoY
    12.55%
    Institutional Ownership
    N/A
    Exchange
    NASDAQ
    ISIN
    US22663K1079

    Price Performance

    Price Change 1M
    1.5%
    Price Change 3M
    145.3%
    Price Change 6M
    122.2%
    Price Change YTD
    81.8%
    Price Change 1Y
    155.1%
    Price Change 3Y
    431.9%
    Price Change 5Y
    244.3%
    1M CAGR (ann.)
    1.5%
    1Y CAGR (ann.)
    155.1%
    5Y CAGR (ann.)
    30.8%
    All-Time CAGR
    16.5%

    Valuation

    PE Ratio
    -16.82
    Forward PE
    N/A
    PEG Ratio
    0.83
    Forward PEG
    1.40
    PS Ratio
    213.54
    Forward PS
    49.90
    PB Ratio
    7.55
    P/FCF Ratio
    -21.17
    P/Adj. FCF Ratio
    -17.17
    P/OCF Ratio
    -21.24
    EV/Sales
    186.06
    EV/EBIT
    -15.29
    EV/EBITDA
    -15.42
    EV/FCF
    -18.45
    Earnings Yield
    -5.9%
    FCF Yield
    -4.7%
    Adj. FCF Yield
    -5.8%

    Financial Health

    Net Cash
    $1.21B
    Total Debt
    $47.19M
    Cash & Short-Term Investments
    $1.21B
    Total Assets
    $1.32B
    Current Ratio
    15.57
    Quick Ratio
    15.53
    Debt / Equity Ratio
    0.04
    Debt / EBITDA
    -0.09
    Debt / FCF
    -0.11
    OCF / Debt
    -8.95
    Interest Coverage
    0.00
    Altman Z-Score
    39.62
    Piotroski F-Score
    3

    Margins & Profitability

    Gross Profit Margin
    99.2%
    Operating Profit Margin
    -1302.5%
    EBITDA Margin
    -1206.9%
    Net Profit Margin
    -1189.9%
    FCF Margin
    -1008.6%
    Adj. FCF Margin
    -1243.4%
    SBC / Revenue
    234.8%
    SBC Impact (per share)
    -23.3%

    Returns

    Return on Assets
    -38.0%
    Return on Equity
    -44.2%
    Return on Invested Capital
    -44.0%
    Return on Capital Employed
    -44.2%
    Return on Tangible Assets
    -38.0%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    105.8%
    Revenue CAGR 5Y
    65.8%
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    -14.8%
    EPS CAGR 5Y
    -13.1%
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    -38.9%
    FCF CAGR 5Y
    -34.7%
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    21
    EPS Growth Next 3Y
    44.1%
    Revenue Growth Next 3Y
    186.0%
    Earnings Date
    Nov 4, 2026
    EPS Estimate (next Q)
    -$1.20
    EPS Growth Est (next Q)
    -13.0%
    Revenue Est (next Q)
    $21.04M
    Revenue Growth Est (next Q)
    14616.3%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $84.86
    Price Target Upside
    -0.1%

    Cash Flow

    Operating Cash Flow
    $-422.52M
    Free Cash Flow
    $-425.18M
    Adj. Free Cash Flow
    $-524.16M
    FCF Per Share
    -$4.03
    OCF Per Share
    -$4
    OCF/S Ratio
    -1002.3%

    Income Statement

    Revenue
    $42.16M
    Gross Profit
    $41.8M
    Operating Income
    $-549.09M
    EBITDA
    $-508.79M
    Net Income
    $-501.61M
    EPS (Diluted)
    -$5.05
    Revenue / Employee
    $70.97K
    Profit / Employee
    $-844.45K
    Employees
    594

    © 2026 bestshares.com. All rights reserved.